Ligne de temps

Agathe Aberlenc
Ingénieur(e) de Recherche
01 mars 2024
publication

Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer.

Lire plus
08 juin 2022
publication

Targeting genome integrity dysfunctions impedes metastatic potency in non-small cell lung cancer circulating tumor cell-derived explants.

Lire plus
16 juil. 2021
publication

Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors.

Lire plus
05 févr. 2021
publication

Tumor Evolution and Therapeutic Choice Seen through a Prism of Circulating Tumor Cell Genomic Instability.

Lire plus
09 oct. 2020
publication

Exploitation of the chick embryo chorioallantoic membrane (CAM) as a platform for anti-metastatic drug testing.

Lire plus
25 sept. 2019
publication

CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs).

Lire plus
01 janv. 2019
publication

Circulating tumor cells (CTCs) for the noninvasive monitoring and personalization of non-small cell lung cancer (NSCLC) therapies.

Lire plus
11 mai 2015
team

Immunologie des Infections Fongiques

Lire plus